Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: Effect of glycemic control and visceral adiposity on Leydig cell function

F. Ermetici, F. Donadio, L. Iorio, A. E. Malavazos, A. Dolci, E. Peverelli, A. M. Barbieri, L. Morricone, I. Chiodini, M. Arosio, A. Lania, P. Beck-Peccoz, B. Ambrosi, S. Corbetta

Research output: Contribution to journalArticle

Abstract

Background and aim: Hypogonadism frequently occurs in men with type 2 diabetes mellitus (T2DM), while the role of glycemic control and visceral obesity is still unclear. This study aimed to assess the Leydig cell function, including the new sensitive marker insulin-like factor 3 (INSL3), in T2DM patients without overt hypogonadism and the influence of either glycemic control or visceral adiposity. Subjects and methods: Thirty T2DM patients (age 57.1±6.2 years, body mass index (BMI) 28.0±4.3) without overt hypogonadism and 30 age- and BMI-matched controls were studied. Anthropometric, glycometabolic parameters and testosterone, SHBG, LH, INSL3 levels, bioavailable and free testosterone (BT and cFT) were evaluated. The human chorionic gonadotrophin (hCG) test was also performed. Results: Patients had lower total testosterone (452.6±130.0 vs 512.6±117.3 ng/dl, P=0.06), BT (189.7±36.4 vs 237.1±94.1 ng/dl, P=0.002), cFT (8.1±1.6 vs 10.1±4.0 ng/dl, P=0.002), and higher LH levels (3.5±1.6 vs 2.6±1.2 mU/ml, P=0.01) versus controls. Serum INSL3 concentrations were also lower in patients (1.1±0.3 vs 1.5±0.7 ng/ml, P=0.01). These hormonal parameters, including INSL3, did not differ between T2DM patients with poor or good glycemic control (HbA1c>9 or

Original languageEnglish
Pages (from-to)853-859
Number of pages7
JournalEuropean Journal of Endocrinology
Volume161
Issue number6
DOIs
Publication statusPublished - 2009

Fingerprint

Leydig Cells
Adiposity
Type 2 Diabetes Mellitus
Hypogonadism
Insulin
Testosterone
Body Mass Index
Abdominal Obesity
Chorionic Gonadotropin
Serum

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus : Effect of glycemic control and visceral adiposity on Leydig cell function. / Ermetici, F.; Donadio, F.; Iorio, L.; Malavazos, A. E.; Dolci, A.; Peverelli, E.; Barbieri, A. M.; Morricone, L.; Chiodini, I.; Arosio, M.; Lania, A.; Beck-Peccoz, P.; Ambrosi, B.; Corbetta, S.

In: European Journal of Endocrinology, Vol. 161, No. 6, 2009, p. 853-859.

Research output: Contribution to journalArticle

@article{e55b03119cc54943998afecc41e8932a,
title = "Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: Effect of glycemic control and visceral adiposity on Leydig cell function",
abstract = "Background and aim: Hypogonadism frequently occurs in men with type 2 diabetes mellitus (T2DM), while the role of glycemic control and visceral obesity is still unclear. This study aimed to assess the Leydig cell function, including the new sensitive marker insulin-like factor 3 (INSL3), in T2DM patients without overt hypogonadism and the influence of either glycemic control or visceral adiposity. Subjects and methods: Thirty T2DM patients (age 57.1±6.2 years, body mass index (BMI) 28.0±4.3) without overt hypogonadism and 30 age- and BMI-matched controls were studied. Anthropometric, glycometabolic parameters and testosterone, SHBG, LH, INSL3 levels, bioavailable and free testosterone (BT and cFT) were evaluated. The human chorionic gonadotrophin (hCG) test was also performed. Results: Patients had lower total testosterone (452.6±130.0 vs 512.6±117.3 ng/dl, P=0.06), BT (189.7±36.4 vs 237.1±94.1 ng/dl, P=0.002), cFT (8.1±1.6 vs 10.1±4.0 ng/dl, P=0.002), and higher LH levels (3.5±1.6 vs 2.6±1.2 mU/ml, P=0.01) versus controls. Serum INSL3 concentrations were also lower in patients (1.1±0.3 vs 1.5±0.7 ng/ml, P=0.01). These hormonal parameters, including INSL3, did not differ between T2DM patients with poor or good glycemic control (HbA1c>9 or",
author = "F. Ermetici and F. Donadio and L. Iorio and Malavazos, {A. E.} and A. Dolci and E. Peverelli and Barbieri, {A. M.} and L. Morricone and I. Chiodini and M. Arosio and A. Lania and P. Beck-Peccoz and B. Ambrosi and S. Corbetta",
year = "2009",
doi = "10.1530/EJE-09-0203",
language = "English",
volume = "161",
pages = "853--859",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "6",

}

TY - JOUR

T1 - Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus

T2 - Effect of glycemic control and visceral adiposity on Leydig cell function

AU - Ermetici, F.

AU - Donadio, F.

AU - Iorio, L.

AU - Malavazos, A. E.

AU - Dolci, A.

AU - Peverelli, E.

AU - Barbieri, A. M.

AU - Morricone, L.

AU - Chiodini, I.

AU - Arosio, M.

AU - Lania, A.

AU - Beck-Peccoz, P.

AU - Ambrosi, B.

AU - Corbetta, S.

PY - 2009

Y1 - 2009

N2 - Background and aim: Hypogonadism frequently occurs in men with type 2 diabetes mellitus (T2DM), while the role of glycemic control and visceral obesity is still unclear. This study aimed to assess the Leydig cell function, including the new sensitive marker insulin-like factor 3 (INSL3), in T2DM patients without overt hypogonadism and the influence of either glycemic control or visceral adiposity. Subjects and methods: Thirty T2DM patients (age 57.1±6.2 years, body mass index (BMI) 28.0±4.3) without overt hypogonadism and 30 age- and BMI-matched controls were studied. Anthropometric, glycometabolic parameters and testosterone, SHBG, LH, INSL3 levels, bioavailable and free testosterone (BT and cFT) were evaluated. The human chorionic gonadotrophin (hCG) test was also performed. Results: Patients had lower total testosterone (452.6±130.0 vs 512.6±117.3 ng/dl, P=0.06), BT (189.7±36.4 vs 237.1±94.1 ng/dl, P=0.002), cFT (8.1±1.6 vs 10.1±4.0 ng/dl, P=0.002), and higher LH levels (3.5±1.6 vs 2.6±1.2 mU/ml, P=0.01) versus controls. Serum INSL3 concentrations were also lower in patients (1.1±0.3 vs 1.5±0.7 ng/ml, P=0.01). These hormonal parameters, including INSL3, did not differ between T2DM patients with poor or good glycemic control (HbA1c>9 or

AB - Background and aim: Hypogonadism frequently occurs in men with type 2 diabetes mellitus (T2DM), while the role of glycemic control and visceral obesity is still unclear. This study aimed to assess the Leydig cell function, including the new sensitive marker insulin-like factor 3 (INSL3), in T2DM patients without overt hypogonadism and the influence of either glycemic control or visceral adiposity. Subjects and methods: Thirty T2DM patients (age 57.1±6.2 years, body mass index (BMI) 28.0±4.3) without overt hypogonadism and 30 age- and BMI-matched controls were studied. Anthropometric, glycometabolic parameters and testosterone, SHBG, LH, INSL3 levels, bioavailable and free testosterone (BT and cFT) were evaluated. The human chorionic gonadotrophin (hCG) test was also performed. Results: Patients had lower total testosterone (452.6±130.0 vs 512.6±117.3 ng/dl, P=0.06), BT (189.7±36.4 vs 237.1±94.1 ng/dl, P=0.002), cFT (8.1±1.6 vs 10.1±4.0 ng/dl, P=0.002), and higher LH levels (3.5±1.6 vs 2.6±1.2 mU/ml, P=0.01) versus controls. Serum INSL3 concentrations were also lower in patients (1.1±0.3 vs 1.5±0.7 ng/ml, P=0.01). These hormonal parameters, including INSL3, did not differ between T2DM patients with poor or good glycemic control (HbA1c>9 or

UR - http://www.scopus.com/inward/record.url?scp=72949086887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949086887&partnerID=8YFLogxK

U2 - 10.1530/EJE-09-0203

DO - 10.1530/EJE-09-0203

M3 - Article

C2 - 19755411

AN - SCOPUS:72949086887

VL - 161

SP - 853

EP - 859

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 6

ER -